{"chebi_id":"7573","chebi_name":"nilutamide","chebi_synonyms":["5,5-dimethyl-3-[4-nitro-3-(trifluoromethyl)phenyl]imidazolidine-2,4-dione","5,5-Dimethyl-3-(\u03b1,\u03b1,\u03b1-trifluoro-4-nitro-m-tolyl)hydantoin","Nilandron","nilutamida","nilutamidum","Nilutamide"],"diffprof_id_observed":["MTBLS2878_0001_00000001","MTBLS673_0001_00000006"],"diffprof_id_var_observed":[],"inchikey":"XWXYUMMDTVBTOU-UHFFFAOYSA-N","inn_name":"nilutamidum","iupac_name":"5,5-dimethyl-3-[4-nitro-3-(trifluoromethyl)phenyl]imidazolidine-2,4-dione","num_study_observed":2,"reactome_ids":["R-HSA-2262752","R-HSA-3371497","R-HSA-8953897"],"reactome_names":["Cellular responses to stress","HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand","Cellular responses to stimuli"],"study_id_observed":["MTBLS2878","MTBLS673"],"study_id_var_observed":[],"synonym_name":"Nilutamide"}